Conclusions and relevance: In this multi-hospital assessment, when controlling for COVID-19 risk factors, treatment with hydroxychloroquine alone and in combination with
conclude that the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status among patients who had been hospitalized
Hydroxychloroquine with or without azithromycin was identified, outside of randomised controlled trials, as an early candidate
News-Medical
Using hydroxychloroquine together with azithromycin can increase the risk of an irregular heart rhythm that may be serious and potentially life
• Significantly reduced hospitalisation
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital
Additional information about dosing and administration appears in chloroquine, was developed in 1946
N Engl J Med
Corpus ID: 219669253; Hidroxicloroquina y azitromicina: riesgo cardiovascular, prolongación de QTc y muerte súbita en el nuevo escenario de la pandemia por COVID-19 Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: a potential risk of Torsades de Pointes
Han S
A PubMed literature search on 14 Jan 2021 with the search terms COVID-19 OR SARS-CoV-2 AND hydroxychloroquine revealed 2144 results; when limited to randomized controlled trials
este mismo también recibió lopinavir/ritonavir y estaba en tratamiento con azitromicina y hidroxicloroquina de forma basal por su
A number of trials evaluating hydroxychloroquine as pre-exposure prophylaxis, as early treatment, and in patients
Patients and methods: French Confirmed COVID-19 patients were included in a single arm protocol from early March to
12th 2020 [3]
ej
corroboraron un efecto potencialmente dañino de la hidroxicloroquina, ivermectina, azitromicina y sus combinaciones